- Home
- IZM vs INKT Comparison
IZM vs INKT Comparison
Compare IZM & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- INKT
- Stock Information
- Founded
- IZM 2011
- INKT 2017
- Country
- IZM China
- INKT United States
- Employees
- IZM N/A
- INKT N/A
- Industry
- IZM Consumer Electronics/Video Chains
- INKT Medicinal Chemicals and Botanical Products
- Sector
- IZM Consumer Discretionary
- INKT Health Care
- Exchange
- IZM Nasdaq
- INKT Nasdaq
- Market Cap
- IZM 23.7M
- INKT 28.5M
- IPO Year
- IZM 2023
- INKT 2021
- Fundamental
- Price
- IZM $1.74
- INKT $0.89
- Analyst Decision
- IZM
- INKT Strong Buy
- Analyst Count
- IZM 0
- INKT 2
- Target Price
- IZM N/A
- INKT $6.50
- AVG Volume (30 Days)
- IZM 64.9K
- INKT 190.7K
- Earning Date
- IZM 01-14-2025
- INKT 11-14-2024
- Dividend Yield
- IZM N/A
- INKT N/A
- EPS Growth
- IZM N/A
- INKT N/A
- EPS
- IZM N/A
- INKT N/A
- Revenue
- IZM $177,933,890.00
- INKT N/A
- Revenue This Year
- IZM N/A
- INKT N/A
- Revenue Next Year
- IZM N/A
- INKT N/A
- P/E Ratio
- IZM N/A
- INKT N/A
- Revenue Growth
- IZM N/A
- INKT N/A
- 52 Week Low
- IZM $1.61
- INKT $0.46
- 52 Week High
- IZM $52.21
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- IZM 28.08
- INKT 65.51
- Support Level
- IZM $1.61
- INKT $0.46
- Resistance Level
- IZM $1.90
- INKT $1.23
- Average True Range (ATR)
- IZM 0.12
- INKT 0.11
- MACD
- IZM -0.04
- INKT 0.05
- Stochastic Oscillator
- IZM 21.31
- INKT 55.28
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.